Comparison of the effect of metformin versus acarbose and metformin in treatment polycystic ovarian syndrome patients
Not Applicable
- Conditions
- polycystic ovarian syndrome.sclerocystic ovary syndrome
- Registration Number
- IRCT2013082214438N1
- Lead Sponsor
- Kermanshah University Of Medical Svience, Research Vice-Presidency
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 68
Inclusion Criteria
age 20-45 years; women with pcos diagnosed by the rotterdam consensus criteria (presence 2 of the following 3 conditions: a)oligomenorrhea /amenorrhea b)clinical or biochemical evidence of hyperandrogenism c)polycystic ovaries on sonography)
Exclusion criteria: patient with systemic disease such as cushing's syndrome; hyper or hypothyroidism; androgen secreting tumor; smokers; any systemic disease (liver ,renal,cardiovascular,diabet mellitus) ; receiving any drug for pcos such as aldacton,dian and clomiphen.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hirsutism. Timepoint: Before intervention - Four months after intervention. Method of measurement: Using Feriedman and Galway Scale.;Testostrone serum level. Timepoint: Before intervention - Four months after intervention. Method of measurement: Serological test with Electr Komolomynsans method.;De Hydro Epi Andrestandion serum level. Timepoint: Before intervention - Four months after intervention. Method of measurement: Serological test with Electr Komolomynsans method.;Fasting insulin serum level. Timepoint: Before intervention - Four months after intervention. Method of measurement: Elysa asses.;Fasting sugar serum level. Timepoint: Before intervention - Four months after intervention. Method of measurement: Enzyme.;Blood pressure. Timepoint: Before intervention - Four months after intervention. Method of measurement: Barometers.
- Secondary Outcome Measures
Name Time Method Triglycerid serum level. Timepoint: Before intervention - Four months after intervention. Method of measurement: Serological test with Electro Komolynsans method.;Cholestrol serum level. Timepoint: Before intervention - Four months after intervention. Method of measurement: Serological test with Electro Komolynsans method.;LDL serum level. Timepoint: Before intervention - Four months after intervention. Method of measurement: Serological test with Electro Komolynsans method.;HDL serum level. Timepoint: Before intervention - Four months after intervention. Method of measurement: Serological test with Electro Komolynsans method.